Skip to main content

Table 1 Baseline Vitiligo European Task Force characteristics of participants starting treatment

From: Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial

Sex  
Female 8
Male 4
Mean Years of Age (range) 18 (12-29)
Fitzpatrick's phototypes  
   I 1
   II 0
   III 0
   IV 2
   V 9
   VI 0
Duration of disease, mean years (range) 5.96 (2-17)
Ethnicity  
   Caucasian 2
   South Asian 9
   South American 1
Disease activity  
   Progressive 7
   Non progressive 5
Previous repigmentation  
   after treatment 11
   spontaneous 0
   no repigmentation 1
Depigmentation on scars 5
Stress at onset 2
Stress as precipitating factor 2
Itch before lesions 3
Vitiligo on genitals 3
Thyroid disease  
   Yes 1
   No 11
Thyroid antibodies  
   Yes 0
   No 9
   unknown 3
Family history of premature gray hair 4
Family history of vitiligo 3
Degree to which vitiligo affects everyday life (out of 10, 10 being the worst) (SD) 3.7 (1.84)
History of autoimmune disease 0
Family history of thyroid or other autoimmune disease 1
Halo Nevus 0
  1. n = 12, SD = standard deviation.